nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA2—myocardium—hypertension	0.00627	0.0384	CbGeAlD
Lithium—GSK3B—myocardium—hypertension	0.00615	0.0377	CbGeAlD
Lithium—IMPA1—heart—hypertension	0.00584	0.0357	CbGeAlD
Lithium—GSK3A—cardiac ventricle—hypertension	0.00569	0.0348	CbGeAlD
Lithium—IMPA1—cardiovascular system—hypertension	0.00551	0.0337	CbGeAlD
Lithium—IMPA1—kidney—hypertension	0.00539	0.033	CbGeAlD
Lithium—GSK3A—myocardium—hypertension	0.00535	0.0328	CbGeAlD
Lithium—GRIA3—adrenal cortex—hypertension	0.00513	0.0314	CbGeAlD
Lithium—IMPA2—nephron tubule—hypertension	0.0046	0.0282	CbGeAlD
Lithium—IMPA2—heart—hypertension	0.00438	0.0268	CbGeAlD
Lithium—GSK3B—heart—hypertension	0.0043	0.0263	CbGeAlD
Lithium—GSK3B—smooth muscle tissue—hypertension	0.00426	0.0261	CbGeAlD
Lithium—IMPA2—decidua—hypertension	0.00426	0.0261	CbGeAlD
Lithium—GSK3B—decidua—hypertension	0.00418	0.0256	CbGeAlD
Lithium—GSK3B—cardiovascular system—hypertension	0.00405	0.0248	CbGeAlD
Lithium—IMPA2—kidney—hypertension	0.00404	0.0248	CbGeAlD
Lithium—GRIA3—medulla oblongata—hypertension	0.004	0.0245	CbGeAlD
Lithium—GSK3B—kidney—hypertension	0.00397	0.0243	CbGeAlD
Lithium—IMPA2—cortex of kidney—hypertension	0.00394	0.0241	CbGeAlD
Lithium—GSK3A—nephron tubule—hypertension	0.00392	0.024	CbGeAlD
Lithium—GSK3A—adrenal cortex—hypertension	0.00386	0.0236	CbGeAlD
Lithium—IMPA1—endocrine gland—hypertension	0.00378	0.0231	CbGeAlD
Lithium—IMPA2—cardiac atrium—hypertension	0.00374	0.0229	CbGeAlD
Lithium—GSK3A—heart—hypertension	0.00374	0.0229	CbGeAlD
Lithium—GSK3A—smooth muscle tissue—hypertension	0.00371	0.0227	CbGeAlD
Lithium—GRIA3—adrenal gland—hypertension	0.0037	0.0227	CbGeAlD
Lithium—GSK3A—decidua—hypertension	0.00363	0.0222	CbGeAlD
Lithium—GSK3A—cardiovascular system—hypertension	0.00352	0.0216	CbGeAlD
Lithium—GSK3B—medulla oblongata—hypertension	0.00346	0.0212	CbGeAlD
Lithium—IMPA1—central nervous system—hypertension	0.0034	0.0208	CbGeAlD
Lithium—GSK3A—cortex of kidney—hypertension	0.00336	0.0206	CbGeAlD
Lithium—IMPA2—adrenal gland—hypertension	0.00327	0.02	CbGeAlD
Lithium—GSK3B—adrenal gland—hypertension	0.00321	0.0196	CbGeAlD
Lithium—GSK3A—cardiac atrium—hypertension	0.00319	0.0196	CbGeAlD
Lithium—GSK3A—medulla oblongata—hypertension	0.00301	0.0184	CbGeAlD
Lithium—GRIA3—central nervous system—hypertension	0.00289	0.0177	CbGeAlD
Lithium—GSK3A—adrenal gland—hypertension	0.00279	0.0171	CbGeAlD
Lithium—GSK3B—endocrine gland—hypertension	0.00278	0.017	CbGeAlD
Lithium—GSK3B—central nervous system—hypertension	0.00251	0.0153	CbGeAlD
Lithium—GSK3A—endocrine gland—hypertension	0.00242	0.0148	CbGeAlD
Lithium—GSK3A—central nervous system—hypertension	0.00218	0.0133	CbGeAlD
Lithium—Fatigue—Betaxolol—hypertension	8.57e-05	0.000187	CcSEcCtD
Lithium—Discomfort—Ramipril—hypertension	8.57e-05	0.000187	CcSEcCtD
Lithium—Asthenia—Olmesartan—hypertension	8.56e-05	0.000187	CcSEcCtD
Lithium—Dizziness—Nifedipine—hypertension	8.55e-05	0.000186	CcSEcCtD
Lithium—Rash—Indapamide—hypertension	8.54e-05	0.000186	CcSEcCtD
Lithium—Rash—Diltiazem—hypertension	8.54e-05	0.000186	CcSEcCtD
Lithium—Dermatitis—Diltiazem—hypertension	8.53e-05	0.000186	CcSEcCtD
Lithium—Dermatitis—Indapamide—hypertension	8.53e-05	0.000186	CcSEcCtD
Lithium—Dyspepsia—Losartan—hypertension	8.53e-05	0.000186	CcSEcCtD
Lithium—Vomiting—Carvedilol—hypertension	8.53e-05	0.000186	CcSEcCtD
Lithium—Feeling abnormal—Perindopril—hypertension	8.51e-05	0.000186	CcSEcCtD
Lithium—Dizziness—Verapamil—hypertension	8.51e-05	0.000186	CcSEcCtD
Lithium—Feeling abnormal—Irbesartan—hypertension	8.49e-05	0.000185	CcSEcCtD
Lithium—Headache—Diltiazem—hypertension	8.48e-05	0.000185	CcSEcCtD
Lithium—Headache—Indapamide—hypertension	8.48e-05	0.000185	CcSEcCtD
Lithium—Dry mouth—Ramipril—hypertension	8.48e-05	0.000185	CcSEcCtD
Lithium—Arthralgia—Timolol—hypertension	8.47e-05	0.000185	CcSEcCtD
Lithium—Rash—Carvedilol—hypertension	8.46e-05	0.000184	CcSEcCtD
Lithium—Gastrointestinal pain—Perindopril—hypertension	8.45e-05	0.000184	CcSEcCtD
Lithium—Dermatitis—Carvedilol—hypertension	8.45e-05	0.000184	CcSEcCtD
Lithium—Angioedema—Lisinopril—hypertension	8.44e-05	0.000184	CcSEcCtD
Lithium—Vomiting—Doxazosin—hypertension	8.43e-05	0.000184	CcSEcCtD
Lithium—Decreased appetite—Losartan—hypertension	8.43e-05	0.000184	CcSEcCtD
Lithium—Gastrointestinal pain—Irbesartan—hypertension	8.42e-05	0.000184	CcSEcCtD
Lithium—Feeling abnormal—Hydrochlorothiazide—hypertension	8.42e-05	0.000184	CcSEcCtD
Lithium—Abdominal pain—Captopril—hypertension	8.41e-05	0.000183	CcSEcCtD
Lithium—Body temperature increased—Captopril—hypertension	8.41e-05	0.000183	CcSEcCtD
Lithium—Headache—Carvedilol—hypertension	8.4e-05	0.000183	CcSEcCtD
Lithium—Confusional state—Ramipril—hypertension	8.38e-05	0.000183	CcSEcCtD
Lithium—Discomfort—Timolol—hypertension	8.37e-05	0.000183	CcSEcCtD
Lithium—Rash—Doxazosin—hypertension	8.36e-05	0.000182	CcSEcCtD
Lithium—Fatigue—Losartan—hypertension	8.36e-05	0.000182	CcSEcCtD
Lithium—Dermatitis—Doxazosin—hypertension	8.36e-05	0.000182	CcSEcCtD
Lithium—Gastrointestinal pain—Hydrochlorothiazide—hypertension	8.35e-05	0.000182	CcSEcCtD
Lithium—Vomiting—Fosinopril—hypertension	8.33e-05	0.000182	CcSEcCtD
Lithium—Nausea—Propranolol—hypertension	8.31e-05	0.000181	CcSEcCtD
Lithium—Oedema—Ramipril—hypertension	8.31e-05	0.000181	CcSEcCtD
Lithium—Headache—Doxazosin—hypertension	8.31e-05	0.000181	CcSEcCtD
Lithium—Vertigo—Lisinopril—hypertension	8.3e-05	0.000181	CcSEcCtD
Lithium—Dry mouth—Timolol—hypertension	8.29e-05	0.000181	CcSEcCtD
Lithium—Syncope—Lisinopril—hypertension	8.28e-05	0.000181	CcSEcCtD
Lithium—Vomiting—Eplerenone—hypertension	8.28e-05	0.000181	CcSEcCtD
Lithium—Feeling abnormal—Furosemide—hypertension	8.28e-05	0.000181	CcSEcCtD
Lithium—Rash—Fosinopril—hypertension	8.26e-05	0.00018	CcSEcCtD
Lithium—Dermatitis—Fosinopril—hypertension	8.25e-05	0.00018	CcSEcCtD
Lithium—Vomiting—Nifedipine—hypertension	8.22e-05	0.000179	CcSEcCtD
Lithium—Gastrointestinal pain—Furosemide—hypertension	8.21e-05	0.000179	CcSEcCtD
Lithium—Rash—Eplerenone—hypertension	8.21e-05	0.000179	CcSEcCtD
Lithium—Headache—Fosinopril—hypertension	8.21e-05	0.000179	CcSEcCtD
Lithium—Dermatitis—Eplerenone—hypertension	8.2e-05	0.000179	CcSEcCtD
Lithium—Diarrhoea—Valsartan—hypertension	8.2e-05	0.000179	CcSEcCtD
Lithium—Asthenia—Clonidine—hypertension	8.2e-05	0.000179	CcSEcCtD
Lithium—Feeling abnormal—Betaxolol—hypertension	8.2e-05	0.000179	CcSEcCtD
Lithium—Confusional state—Timolol—hypertension	8.19e-05	0.000179	CcSEcCtD
Lithium—Vomiting—Verapamil—hypertension	8.18e-05	0.000178	CcSEcCtD
Lithium—Shock—Ramipril—hypertension	8.18e-05	0.000178	CcSEcCtD
Lithium—Body temperature increased—Perindopril—hypertension	8.17e-05	0.000178	CcSEcCtD
Lithium—Abdominal pain—Perindopril—hypertension	8.17e-05	0.000178	CcSEcCtD
Lithium—Diarrhoea—Olmesartan—hypertension	8.16e-05	0.000178	CcSEcCtD
Lithium—Headache—Eplerenone—hypertension	8.16e-05	0.000178	CcSEcCtD
Lithium—Rash—Nifedipine—hypertension	8.15e-05	0.000178	CcSEcCtD
Lithium—Dermatitis—Nifedipine—hypertension	8.14e-05	0.000178	CcSEcCtD
Lithium—Abdominal pain—Irbesartan—hypertension	8.14e-05	0.000178	CcSEcCtD
Lithium—Body temperature increased—Irbesartan—hypertension	8.14e-05	0.000178	CcSEcCtD
Lithium—Oedema—Timolol—hypertension	8.12e-05	0.000177	CcSEcCtD
Lithium—Loss of consciousness—Lisinopril—hypertension	8.12e-05	0.000177	CcSEcCtD
Lithium—Rash—Verapamil—hypertension	8.12e-05	0.000177	CcSEcCtD
Lithium—Dermatitis—Verapamil—hypertension	8.11e-05	0.000177	CcSEcCtD
Lithium—Headache—Nifedipine—hypertension	8.1e-05	0.000177	CcSEcCtD
Lithium—Abdominal pain—Hydrochlorothiazide—hypertension	8.07e-05	0.000176	CcSEcCtD
Lithium—Body temperature increased—Hydrochlorothiazide—hypertension	8.07e-05	0.000176	CcSEcCtD
Lithium—Headache—Verapamil—hypertension	8.06e-05	0.000176	CcSEcCtD
Lithium—Nausea—Indapamide—hypertension	8.04e-05	0.000175	CcSEcCtD
Lithium—Nausea—Diltiazem—hypertension	8.04e-05	0.000175	CcSEcCtD
Lithium—Asthenia—Trandolapril—hypertension	7.99e-05	0.000174	CcSEcCtD
Lithium—Shock—Timolol—hypertension	7.99e-05	0.000174	CcSEcCtD
Lithium—Feeling abnormal—Losartan—hypertension	7.99e-05	0.000174	CcSEcCtD
Lithium—Nausea—Carvedilol—hypertension	7.97e-05	0.000174	CcSEcCtD
Lithium—Asthenia—Enalapril—hypertension	7.96e-05	0.000174	CcSEcCtD
Lithium—Body temperature increased—Furosemide—hypertension	7.94e-05	0.000173	CcSEcCtD
Lithium—Abdominal pain—Furosemide—hypertension	7.94e-05	0.000173	CcSEcCtD
Lithium—Gastrointestinal pain—Losartan—hypertension	7.93e-05	0.000173	CcSEcCtD
Lithium—Dizziness—Valsartan—hypertension	7.92e-05	0.000173	CcSEcCtD
Lithium—Anorexia—Ramipril—hypertension	7.92e-05	0.000173	CcSEcCtD
Lithium—Dizziness—Olmesartan—hypertension	7.89e-05	0.000172	CcSEcCtD
Lithium—Nausea—Doxazosin—hypertension	7.88e-05	0.000172	CcSEcCtD
Lithium—Arthralgia—Lisinopril—hypertension	7.86e-05	0.000171	CcSEcCtD
Lithium—Body temperature increased—Betaxolol—hypertension	7.86e-05	0.000171	CcSEcCtD
Lithium—Asthenia—Telmisartan—hypertension	7.85e-05	0.000171	CcSEcCtD
Lithium—Diarrhoea—Clonidine—hypertension	7.82e-05	0.00017	CcSEcCtD
Lithium—Nausea—Fosinopril—hypertension	7.78e-05	0.00017	CcSEcCtD
Lithium—Discomfort—Lisinopril—hypertension	7.77e-05	0.000169	CcSEcCtD
Lithium—Hypotension—Ramipril—hypertension	7.77e-05	0.000169	CcSEcCtD
Lithium—Anorexia—Timolol—hypertension	7.74e-05	0.000169	CcSEcCtD
Lithium—Nausea—Eplerenone—hypertension	7.74e-05	0.000169	CcSEcCtD
Lithium—Dry mouth—Lisinopril—hypertension	7.69e-05	0.000168	CcSEcCtD
Lithium—Nausea—Nifedipine—hypertension	7.68e-05	0.000167	CcSEcCtD
Lithium—Abdominal pain—Losartan—hypertension	7.66e-05	0.000167	CcSEcCtD
Lithium—Body temperature increased—Losartan—hypertension	7.66e-05	0.000167	CcSEcCtD
Lithium—Nausea—Verapamil—hypertension	7.65e-05	0.000167	CcSEcCtD
Lithium—Asthenia—Captopril—hypertension	7.64e-05	0.000167	CcSEcCtD
Lithium—Diarrhoea—Trandolapril—hypertension	7.62e-05	0.000166	CcSEcCtD
Lithium—Vomiting—Valsartan—hypertension	7.62e-05	0.000166	CcSEcCtD
Lithium—Confusional state—Lisinopril—hypertension	7.6e-05	0.000166	CcSEcCtD
Lithium—Diarrhoea—Enalapril—hypertension	7.59e-05	0.000166	CcSEcCtD
Lithium—Hypotension—Timolol—hypertension	7.59e-05	0.000166	CcSEcCtD
Lithium—Vomiting—Olmesartan—hypertension	7.58e-05	0.000165	CcSEcCtD
Lithium—Musculoskeletal discomfort—Ramipril—hypertension	7.57e-05	0.000165	CcSEcCtD
Lithium—Rash—Valsartan—hypertension	7.56e-05	0.000165	CcSEcCtD
Lithium—Dizziness—Clonidine—hypertension	7.55e-05	0.000165	CcSEcCtD
Lithium—Dermatitis—Valsartan—hypertension	7.55e-05	0.000165	CcSEcCtD
Lithium—Oedema—Lisinopril—hypertension	7.54e-05	0.000164	CcSEcCtD
Lithium—Rash—Olmesartan—hypertension	7.52e-05	0.000164	CcSEcCtD
Lithium—Dermatitis—Olmesartan—hypertension	7.51e-05	0.000164	CcSEcCtD
Lithium—Headache—Valsartan—hypertension	7.51e-05	0.000164	CcSEcCtD
Lithium—Diarrhoea—Telmisartan—hypertension	7.49e-05	0.000163	CcSEcCtD
Lithium—Headache—Olmesartan—hypertension	7.47e-05	0.000163	CcSEcCtD
Lithium—Shock—Lisinopril—hypertension	7.41e-05	0.000162	CcSEcCtD
Lithium—Asthenia—Perindopril—hypertension	7.41e-05	0.000162	CcSEcCtD
Lithium—Musculoskeletal discomfort—Timolol—hypertension	7.4e-05	0.000161	CcSEcCtD
Lithium—Asthenia—Irbesartan—hypertension	7.39e-05	0.000161	CcSEcCtD
Lithium—Somnolence—Ramipril—hypertension	7.39e-05	0.000161	CcSEcCtD
Lithium—Dizziness—Trandolapril—hypertension	7.37e-05	0.000161	CcSEcCtD
Lithium—Dizziness—Enalapril—hypertension	7.34e-05	0.00016	CcSEcCtD
Lithium—Asthenia—Hydrochlorothiazide—hypertension	7.33e-05	0.00016	CcSEcCtD
Lithium—Dyspepsia—Ramipril—hypertension	7.32e-05	0.00016	CcSEcCtD
Lithium—Diarrhoea—Captopril—hypertension	7.28e-05	0.000159	CcSEcCtD
Lithium—Vomiting—Clonidine—hypertension	7.26e-05	0.000158	CcSEcCtD
Lithium—Dizziness—Telmisartan—hypertension	7.24e-05	0.000158	CcSEcCtD
Lithium—Decreased appetite—Ramipril—hypertension	7.22e-05	0.000158	CcSEcCtD
Lithium—Somnolence—Timolol—hypertension	7.22e-05	0.000158	CcSEcCtD
Lithium—Asthenia—Furosemide—hypertension	7.21e-05	0.000157	CcSEcCtD
Lithium—Rash—Clonidine—hypertension	7.2e-05	0.000157	CcSEcCtD
Lithium—Dermatitis—Clonidine—hypertension	7.2e-05	0.000157	CcSEcCtD
Lithium—Anorexia—Lisinopril—hypertension	7.18e-05	0.000157	CcSEcCtD
Lithium—Fatigue—Ramipril—hypertension	7.16e-05	0.000156	CcSEcCtD
Lithium—Headache—Clonidine—hypertension	7.16e-05	0.000156	CcSEcCtD
Lithium—Dyspepsia—Timolol—hypertension	7.15e-05	0.000156	CcSEcCtD
Lithium—Asthenia—Betaxolol—hypertension	7.14e-05	0.000156	CcSEcCtD
Lithium—Nausea—Valsartan—hypertension	7.12e-05	0.000155	CcSEcCtD
Lithium—Nausea—Olmesartan—hypertension	7.08e-05	0.000154	CcSEcCtD
Lithium—Vomiting—Trandolapril—hypertension	7.08e-05	0.000154	CcSEcCtD
Lithium—Diarrhoea—Perindopril—hypertension	7.07e-05	0.000154	CcSEcCtD
Lithium—Decreased appetite—Timolol—hypertension	7.06e-05	0.000154	CcSEcCtD
Lithium—Vomiting—Enalapril—hypertension	7.05e-05	0.000154	CcSEcCtD
Lithium—Diarrhoea—Irbesartan—hypertension	7.05e-05	0.000154	CcSEcCtD
Lithium—Hypotension—Lisinopril—hypertension	7.04e-05	0.000154	CcSEcCtD
Lithium—Dizziness—Captopril—hypertension	7.04e-05	0.000153	CcSEcCtD
Lithium—Rash—Trandolapril—hypertension	7.02e-05	0.000153	CcSEcCtD
Lithium—Dermatitis—Trandolapril—hypertension	7.02e-05	0.000153	CcSEcCtD
Lithium—Fatigue—Timolol—hypertension	7e-05	0.000153	CcSEcCtD
Lithium—Rash—Enalapril—hypertension	7e-05	0.000153	CcSEcCtD
Lithium—Dermatitis—Enalapril—hypertension	6.99e-05	0.000152	CcSEcCtD
Lithium—Diarrhoea—Hydrochlorothiazide—hypertension	6.99e-05	0.000152	CcSEcCtD
Lithium—Headache—Trandolapril—hypertension	6.98e-05	0.000152	CcSEcCtD
Lithium—Vomiting—Telmisartan—hypertension	6.96e-05	0.000152	CcSEcCtD
Lithium—Asthenia—Losartan—hypertension	6.95e-05	0.000152	CcSEcCtD
Lithium—Headache—Enalapril—hypertension	6.95e-05	0.000152	CcSEcCtD
Lithium—Rash—Telmisartan—hypertension	6.9e-05	0.00015	CcSEcCtD
Lithium—Dermatitis—Telmisartan—hypertension	6.89e-05	0.00015	CcSEcCtD
Lithium—Diarrhoea—Furosemide—hypertension	6.87e-05	0.00015	CcSEcCtD
Lithium—Musculoskeletal discomfort—Lisinopril—hypertension	6.87e-05	0.00015	CcSEcCtD
Lithium—Headache—Telmisartan—hypertension	6.86e-05	0.00015	CcSEcCtD
Lithium—Feeling abnormal—Ramipril—hypertension	6.85e-05	0.000149	CcSEcCtD
Lithium—Dizziness—Perindopril—hypertension	6.83e-05	0.000149	CcSEcCtD
Lithium—Dizziness—Irbesartan—hypertension	6.81e-05	0.000149	CcSEcCtD
Lithium—Diarrhoea—Betaxolol—hypertension	6.8e-05	0.000148	CcSEcCtD
Lithium—Gastrointestinal pain—Ramipril—hypertension	6.8e-05	0.000148	CcSEcCtD
Lithium—Nausea—Clonidine—hypertension	6.78e-05	0.000148	CcSEcCtD
Lithium—Vomiting—Captopril—hypertension	6.77e-05	0.000148	CcSEcCtD
Lithium—Dizziness—Hydrochlorothiazide—hypertension	6.75e-05	0.000147	CcSEcCtD
Lithium—Rash—Captopril—hypertension	6.71e-05	0.000146	CcSEcCtD
Lithium—Dermatitis—Captopril—hypertension	6.7e-05	0.000146	CcSEcCtD
Lithium—Somnolence—Lisinopril—hypertension	6.7e-05	0.000146	CcSEcCtD
Lithium—Feeling abnormal—Timolol—hypertension	6.69e-05	0.000146	CcSEcCtD
Lithium—Headache—Captopril—hypertension	6.67e-05	0.000145	CcSEcCtD
Lithium—Gastrointestinal pain—Timolol—hypertension	6.64e-05	0.000145	CcSEcCtD
Lithium—Dizziness—Furosemide—hypertension	6.64e-05	0.000145	CcSEcCtD
Lithium—Dyspepsia—Lisinopril—hypertension	6.63e-05	0.000145	CcSEcCtD
Lithium—Diarrhoea—Losartan—hypertension	6.63e-05	0.000145	CcSEcCtD
Lithium—Nausea—Trandolapril—hypertension	6.62e-05	0.000144	CcSEcCtD
Lithium—Nausea—Enalapril—hypertension	6.59e-05	0.000144	CcSEcCtD
Lithium—Dizziness—Betaxolol—hypertension	6.58e-05	0.000143	CcSEcCtD
Lithium—Vomiting—Perindopril—hypertension	6.57e-05	0.000143	CcSEcCtD
Lithium—Abdominal pain—Ramipril—hypertension	6.57e-05	0.000143	CcSEcCtD
Lithium—Body temperature increased—Ramipril—hypertension	6.57e-05	0.000143	CcSEcCtD
Lithium—Decreased appetite—Lisinopril—hypertension	6.55e-05	0.000143	CcSEcCtD
Lithium—Vomiting—Irbesartan—hypertension	6.55e-05	0.000143	CcSEcCtD
Lithium—Rash—Perindopril—hypertension	6.52e-05	0.000142	CcSEcCtD
Lithium—Dermatitis—Perindopril—hypertension	6.51e-05	0.000142	CcSEcCtD
Lithium—Nausea—Telmisartan—hypertension	6.5e-05	0.000142	CcSEcCtD
Lithium—Fatigue—Lisinopril—hypertension	6.5e-05	0.000142	CcSEcCtD
Lithium—Vomiting—Hydrochlorothiazide—hypertension	6.49e-05	0.000142	CcSEcCtD
Lithium—Rash—Irbesartan—hypertension	6.49e-05	0.000142	CcSEcCtD
Lithium—Dermatitis—Irbesartan—hypertension	6.49e-05	0.000141	CcSEcCtD
Lithium—Headache—Perindopril—hypertension	6.47e-05	0.000141	CcSEcCtD
Lithium—Headache—Irbesartan—hypertension	6.45e-05	0.000141	CcSEcCtD
Lithium—Rash—Hydrochlorothiazide—hypertension	6.44e-05	0.00014	CcSEcCtD
Lithium—Dermatitis—Hydrochlorothiazide—hypertension	6.43e-05	0.00014	CcSEcCtD
Lithium—Abdominal pain—Timolol—hypertension	6.42e-05	0.00014	CcSEcCtD
Lithium—Body temperature increased—Timolol—hypertension	6.42e-05	0.00014	CcSEcCtD
Lithium—Dizziness—Losartan—hypertension	6.41e-05	0.00014	CcSEcCtD
Lithium—Headache—Hydrochlorothiazide—hypertension	6.4e-05	0.00014	CcSEcCtD
Lithium—Vomiting—Furosemide—hypertension	6.39e-05	0.000139	CcSEcCtD
Lithium—Rash—Furosemide—hypertension	6.33e-05	0.000138	CcSEcCtD
Lithium—Dermatitis—Furosemide—hypertension	6.33e-05	0.000138	CcSEcCtD
Lithium—Vomiting—Betaxolol—hypertension	6.32e-05	0.000138	CcSEcCtD
Lithium—Nausea—Captopril—hypertension	6.32e-05	0.000138	CcSEcCtD
Lithium—Headache—Furosemide—hypertension	6.29e-05	0.000137	CcSEcCtD
Lithium—Rash—Betaxolol—hypertension	6.27e-05	0.000137	CcSEcCtD
Lithium—Dermatitis—Betaxolol—hypertension	6.26e-05	0.000137	CcSEcCtD
Lithium—Headache—Betaxolol—hypertension	6.23e-05	0.000136	CcSEcCtD
Lithium—Feeling abnormal—Lisinopril—hypertension	6.21e-05	0.000135	CcSEcCtD
Lithium—Gastrointestinal pain—Lisinopril—hypertension	6.16e-05	0.000134	CcSEcCtD
Lithium—Vomiting—Losartan—hypertension	6.16e-05	0.000134	CcSEcCtD
Lithium—Nausea—Perindopril—hypertension	6.14e-05	0.000134	CcSEcCtD
Lithium—Nausea—Irbesartan—hypertension	6.12e-05	0.000133	CcSEcCtD
Lithium—Rash—Losartan—hypertension	6.11e-05	0.000133	CcSEcCtD
Lithium—Dermatitis—Losartan—hypertension	6.11e-05	0.000133	CcSEcCtD
Lithium—Headache—Losartan—hypertension	6.07e-05	0.000132	CcSEcCtD
Lithium—Nausea—Hydrochlorothiazide—hypertension	6.07e-05	0.000132	CcSEcCtD
Lithium—Nausea—Furosemide—hypertension	5.97e-05	0.00013	CcSEcCtD
Lithium—Asthenia—Ramipril—hypertension	5.96e-05	0.00013	CcSEcCtD
Lithium—Body temperature increased—Lisinopril—hypertension	5.96e-05	0.00013	CcSEcCtD
Lithium—Abdominal pain—Lisinopril—hypertension	5.96e-05	0.00013	CcSEcCtD
Lithium—Nausea—Betaxolol—hypertension	5.91e-05	0.000129	CcSEcCtD
Lithium—Asthenia—Timolol—hypertension	5.83e-05	0.000127	CcSEcCtD
Lithium—Nausea—Losartan—hypertension	5.76e-05	0.000126	CcSEcCtD
Lithium—Diarrhoea—Ramipril—hypertension	5.69e-05	0.000124	CcSEcCtD
Lithium—Diarrhoea—Timolol—hypertension	5.56e-05	0.000121	CcSEcCtD
Lithium—Dizziness—Ramipril—hypertension	5.5e-05	0.00012	CcSEcCtD
Lithium—Asthenia—Lisinopril—hypertension	5.41e-05	0.000118	CcSEcCtD
Lithium—Dizziness—Timolol—hypertension	5.37e-05	0.000117	CcSEcCtD
Lithium—Vomiting—Ramipril—hypertension	5.28e-05	0.000115	CcSEcCtD
Lithium—Rash—Ramipril—hypertension	5.24e-05	0.000114	CcSEcCtD
Lithium—Dermatitis—Ramipril—hypertension	5.23e-05	0.000114	CcSEcCtD
Lithium—Headache—Ramipril—hypertension	5.21e-05	0.000114	CcSEcCtD
Lithium—Vomiting—Timolol—hypertension	5.17e-05	0.000113	CcSEcCtD
Lithium—Diarrhoea—Lisinopril—hypertension	5.16e-05	0.000112	CcSEcCtD
Lithium—Rash—Timolol—hypertension	5.12e-05	0.000112	CcSEcCtD
Lithium—Dermatitis—Timolol—hypertension	5.12e-05	0.000112	CcSEcCtD
Lithium—Headache—Timolol—hypertension	5.09e-05	0.000111	CcSEcCtD
Lithium—Dizziness—Lisinopril—hypertension	4.98e-05	0.000109	CcSEcCtD
Lithium—Nausea—Ramipril—hypertension	4.94e-05	0.000108	CcSEcCtD
Lithium—Nausea—Timolol—hypertension	4.83e-05	0.000105	CcSEcCtD
Lithium—Vomiting—Lisinopril—hypertension	4.79e-05	0.000105	CcSEcCtD
Lithium—Rash—Lisinopril—hypertension	4.75e-05	0.000104	CcSEcCtD
Lithium—Dermatitis—Lisinopril—hypertension	4.75e-05	0.000104	CcSEcCtD
Lithium—Headache—Lisinopril—hypertension	4.72e-05	0.000103	CcSEcCtD
Lithium—Nausea—Lisinopril—hypertension	4.48e-05	9.76e-05	CcSEcCtD
Lithium—GSK3B—Developmental Biology—VEGFA—hypertension	1.89e-05	5e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PDGFB—hypertension	1.88e-05	4.98e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LPL—hypertension	1.88e-05	4.98e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGFR1—hypertension	1.88e-05	4.96e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—BDKRB2—hypertension	1.87e-05	4.94e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT1—hypertension	1.87e-05	4.94e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—H2AFX—hypertension	1.87e-05	4.94e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RPS6KB1—hypertension	1.87e-05	4.93e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PDGFRB—hypertension	1.87e-05	4.93e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT2—hypertension	1.86e-05	4.92e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CDKN1A—hypertension	1.85e-05	4.9e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF2—hypertension	1.85e-05	4.9e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PTEN—hypertension	1.85e-05	4.89e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRBK1—hypertension	1.85e-05	4.89e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADCY5—hypertension	1.84e-05	4.87e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—hypertension	1.84e-05	4.87e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CNR1—hypertension	1.84e-05	4.85e-05	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—hypertension	1.83e-05	4.85e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCG—hypertension	1.83e-05	4.84e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PRKCD—hypertension	1.83e-05	4.84e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CCR5—hypertension	1.83e-05	4.84e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3R1—hypertension	1.83e-05	4.83e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ITGB3—hypertension	1.82e-05	4.81e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCA—hypertension	1.82e-05	4.81e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CALM2—hypertension	1.82e-05	4.8e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK8—hypertension	1.81e-05	4.79e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CALM1—hypertension	1.81e-05	4.78e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—YWHAZ—hypertension	1.8e-05	4.77e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR7—hypertension	1.79e-05	4.73e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD2—hypertension	1.79e-05	4.73e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—hypertension	1.79e-05	4.73e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NGF—hypertension	1.78e-05	4.71e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SPP1—hypertension	1.78e-05	4.71e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDKN1A—hypertension	1.78e-05	4.71e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PTEN—hypertension	1.78e-05	4.7e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GCG—hypertension	1.77e-05	4.69e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTPN1—hypertension	1.77e-05	4.69e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—SERPINE1—hypertension	1.77e-05	4.67e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EP300—hypertension	1.76e-05	4.66e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—BCL2—hypertension	1.76e-05	4.65e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PDGFB—hypertension	1.74e-05	4.6e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOTCH2—hypertension	1.74e-05	4.6e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KL—hypertension	1.74e-05	4.6e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—hypertension	1.74e-05	4.59e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR5—hypertension	1.73e-05	4.59e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCD—hypertension	1.73e-05	4.59e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—FGFR1—hypertension	1.73e-05	4.58e-05	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AKT1—hypertension	1.73e-05	4.56e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT1—hypertension	1.72e-05	4.55e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—RELA—hypertension	1.72e-05	4.55e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—SRC—hypertension	1.72e-05	4.54e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF2—hypertension	1.71e-05	4.53e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ITGAV—hypertension	1.71e-05	4.51e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NGFR—hypertension	1.71e-05	4.51e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—RHOA—hypertension	1.71e-05	4.51e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—HIF1A—hypertension	1.71e-05	4.51e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—EGFR—hypertension	1.7e-05	4.5e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KNG1—hypertension	1.7e-05	4.5e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKCB—hypertension	1.7e-05	4.5e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—hypertension	1.7e-05	4.49e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—C3—hypertension	1.69e-05	4.48e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—ICAM1—hypertension	1.69e-05	4.48e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRL—hypertension	1.69e-05	4.47e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGTR1—hypertension	1.69e-05	4.47e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3R1—hypertension	1.69e-05	4.46e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—hypertension	1.69e-05	4.46e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MTOR—hypertension	1.69e-05	4.46e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CALM1—hypertension	1.67e-05	4.42e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STK11—hypertension	1.67e-05	4.41e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HDAC1—hypertension	1.67e-05	4.41e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—hypertension	1.66e-05	4.4e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL10—hypertension	1.65e-05	4.37e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CAV1—hypertension	1.65e-05	4.36e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PDGFB—hypertension	1.65e-05	4.36e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLG—hypertension	1.65e-05	4.36e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—SRC—hypertension	1.65e-05	4.36e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOA1—hypertension	1.65e-05	4.35e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGFR1—hypertension	1.64e-05	4.34e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—hypertension	1.62e-05	4.29e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HIF1A—hypertension	1.62e-05	4.27e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AGT—hypertension	1.61e-05	4.26e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB2—hypertension	1.6e-05	4.24e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCE—hypertension	1.58e-05	4.19e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CALM1—hypertension	1.58e-05	4.19e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—hypertension	1.58e-05	4.17e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—hypertension	1.58e-05	4.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PDGFA—hypertension	1.56e-05	4.14e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VAV3—hypertension	1.56e-05	4.14e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—hypertension	1.56e-05	4.14e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CAV1—hypertension	1.56e-05	4.13e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOA1—hypertension	1.56e-05	4.12e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MTOR—hypertension	1.56e-05	4.12e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—hypertension	1.56e-05	4.11e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FOS—hypertension	1.55e-05	4.1e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS2—hypertension	1.55e-05	4.1e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KDR—hypertension	1.55e-05	4.09e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—hypertension	1.54e-05	4.08e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFBR2—hypertension	1.54e-05	4.08e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOTCH1—hypertension	1.54e-05	4.06e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNB3—hypertension	1.53e-05	4.04e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AVP—hypertension	1.51e-05	3.98e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EGFR—hypertension	1.5e-05	3.98e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT2—hypertension	1.49e-05	3.94e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—F2—hypertension	1.49e-05	3.93e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FN1—hypertension	1.49e-05	3.93e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCB—hypertension	1.49e-05	3.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNAS—hypertension	1.49e-05	3.93e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDKN1A—hypertension	1.46e-05	3.86e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PTEN—hypertension	1.46e-05	3.86e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOB—hypertension	1.46e-05	3.85e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOTCH1—hypertension	1.46e-05	3.85e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTK2—hypertension	1.45e-05	3.84e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—EGFR—hypertension	1.44e-05	3.82e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT1—hypertension	1.44e-05	3.81e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EDN1—hypertension	1.43e-05	3.79e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK8—hypertension	1.43e-05	3.77e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL5—hypertension	1.42e-05	3.76e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—hypertension	1.42e-05	3.76e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LPL—hypertension	1.39e-05	3.68e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—EP300—hypertension	1.39e-05	3.68e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT1—hypertension	1.39e-05	3.66e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—H2AFX—hypertension	1.38e-05	3.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RPS6KB1—hypertension	1.38e-05	3.64e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PDGFRB—hypertension	1.38e-05	3.64e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT2—hypertension	1.37e-05	3.63e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF2—hypertension	1.37e-05	3.62e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADCY5—hypertension	1.36e-05	3.6e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—hypertension	1.36e-05	3.58e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCG—hypertension	1.35e-05	3.58e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—SRC—hypertension	1.35e-05	3.58e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3R1—hypertension	1.35e-05	3.57e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—CDKN1A—hypertension	1.35e-05	3.57e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—hypertension	1.35e-05	3.56e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PTEN—hypertension	1.35e-05	3.56e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ITGB3—hypertension	1.34e-05	3.55e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCA—hypertension	1.34e-05	3.55e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—YWHAZ—hypertension	1.33e-05	3.52e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL2—hypertension	1.33e-05	3.51e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NGF—hypertension	1.32e-05	3.48e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SPP1—hypertension	1.32e-05	3.48e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—hypertension	1.31e-05	3.46e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—SERPINE1—hypertension	1.31e-05	3.45e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—hypertension	1.3e-05	3.45e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT2—hypertension	1.3e-05	3.44e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2—hypertension	1.3e-05	3.44e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—EP300—hypertension	1.28e-05	3.39e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCD—hypertension	1.28e-05	3.39e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR5—hypertension	1.28e-05	3.39e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—RELA—hypertension	1.27e-05	3.36e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF2—hypertension	1.26e-05	3.34e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—RHOA—hypertension	1.26e-05	3.33e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—hypertension	1.25e-05	3.32e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—C3—hypertension	1.25e-05	3.31e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—SRC—hypertension	1.25e-05	3.3e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—hypertension	1.25e-05	3.3e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3R1—hypertension	1.25e-05	3.3e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MTOR—hypertension	1.25e-05	3.3e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SERPINE1—hypertension	1.24e-05	3.27e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PDGFB—hypertension	1.22e-05	3.22e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGFR1—hypertension	1.21e-05	3.21e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT1—hypertension	1.21e-05	3.19e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF2—hypertension	1.2e-05	3.17e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RHOA—hypertension	1.19e-05	3.16e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HIF1A—hypertension	1.19e-05	3.16e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGT—hypertension	1.19e-05	3.15e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—EGFR—hypertension	1.19e-05	3.13e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—hypertension	1.18e-05	3.13e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3R1—hypertension	1.18e-05	3.13e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CALM1—hypertension	1.17e-05	3.09e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—hypertension	1.17e-05	3.08e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—hypertension	1.17e-05	3.08e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—hypertension	1.16e-05	3.06e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CAV1—hypertension	1.15e-05	3.05e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOA1—hypertension	1.15e-05	3.05e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MTOR—hypertension	1.15e-05	3.04e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—hypertension	1.15e-05	3.04e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KDR—hypertension	1.14e-05	3.02e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—hypertension	1.14e-05	3.02e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—hypertension	1.12e-05	2.96e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—hypertension	1.12e-05	2.95e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RELA—hypertension	1.11e-05	2.94e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—F2—hypertension	1.1e-05	2.91e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCB—hypertension	1.1e-05	2.91e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FN1—hypertension	1.1e-05	2.91e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—EGFR—hypertension	1.09e-05	2.89e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MTOR—hypertension	1.09e-05	2.88e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDKN1A—hypertension	1.08e-05	2.86e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTEN—hypertension	1.08e-05	2.85e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOTCH1—hypertension	1.08e-05	2.84e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT1—hypertension	1.07e-05	2.82e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK8—hypertension	1.05e-05	2.79e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL8—hypertension	1.05e-05	2.77e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—EP300—hypertension	1.03e-05	2.72e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT1—hypertension	1.02e-05	2.71e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—hypertension	1e-05	2.65e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—SRC—hypertension	9.99e-06	2.64e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CDKN1A—hypertension	9.97e-06	2.64e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—hypertension	9.96e-06	2.63e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PTEN—hypertension	9.95e-06	2.63e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL2—hypertension	9.8e-06	2.59e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—hypertension	9.63e-06	2.55e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT2—hypertension	9.63e-06	2.55e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—EP300—hypertension	9.49e-06	2.51e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP9—hypertension	9.48e-06	2.51e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDKN1A—hypertension	9.45e-06	2.5e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTEN—hypertension	9.43e-06	2.49e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—SRC—hypertension	9.22e-06	2.44e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK8—hypertension	9.22e-06	2.44e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SERPINE1—hypertension	9.15e-06	2.42e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—hypertension	9.11e-06	2.41e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EP300—hypertension	8.99e-06	2.38e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF2—hypertension	8.86e-06	2.34e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RHOA—hypertension	8.82e-06	2.33e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—EGFR—hypertension	8.76e-06	2.32e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SRC—hypertension	8.74e-06	2.31e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3R1—hypertension	8.73e-06	2.31e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—hypertension	8.73e-06	2.31e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VEGFA—hypertension	8.51e-06	2.25e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—hypertension	8.41e-06	2.22e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT1—hypertension	8.4e-06	2.22e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—hypertension	8.27e-06	2.19e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—hypertension	8.25e-06	2.18e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RELA—hypertension	8.22e-06	2.17e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—EGFR—hypertension	8.09e-06	2.14e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MTOR—hypertension	8.06e-06	2.13e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—hypertension	7.83e-06	2.07e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—hypertension	7.81e-06	2.07e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT1—hypertension	7.76e-06	2.05e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL8—hypertension	7.75e-06	2.05e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EGFR—hypertension	7.66e-06	2.03e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP9—hypertension	7.01e-06	1.85e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDKN1A—hypertension	6.98e-06	1.85e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTEN—hypertension	6.97e-06	1.84e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK8—hypertension	6.81e-06	1.8e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—hypertension	6.73e-06	1.78e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EP300—hypertension	6.64e-06	1.76e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SRC—hypertension	6.46e-06	1.71e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—hypertension	6.43e-06	1.7e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VEGFA—hypertension	6.29e-06	1.66e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—hypertension	6.21e-06	1.64e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT1—hypertension	6.21e-06	1.64e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—hypertension	5.89e-06	1.56e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—hypertension	5.79e-06	1.53e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—hypertension	5.77e-06	1.53e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT1—hypertension	5.73e-06	1.52e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EGFR—hypertension	5.66e-06	1.5e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT1—hypertension	5.43e-06	1.44e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—hypertension	4.75e-06	1.26e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—hypertension	4.35e-06	1.15e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT1—hypertension	4.01e-06	1.06e-05	CbGpPWpGaD
